North America molecular point of care testing (using NAAT) market is expected to reach USD 34,736.47 million by 2028, from USD 12,711.40 million in 2020, growing at the CAGR of 12.1% in the forecast period of 2021 to 2028.
POCT devices now entering into clinical use are based on nucleic acid amplification technologies (NAAT), defined here as second-generation devices. These platforms generally have improved sensitivity, typically in the range of 60 to 90%, compared to first-generation POCTs, and require portable instrumentation with a footprint of approximately 30cm x 30cm. These instruments are essentially used in the molecular detection of various disorders such as HIV, HPV, and respiratory disease through NAAT technology. NAAT is Nucleic Acid Amplification Techniques which allows identification of pathogenic organisms by detecting their DNA or RNA.
Market Analysis and Insights
This North America molecular point of care testing (using NAAT) market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
Molecular point-of-care testing's significant advantages include the rapid diagnosis process, treatment choice, monitoring, and prognosis. This will also help in operational decision-making and proper resource utilization. The increasing prevalence of chronic disease and increasing diagnosis-seeking rate are expected to act as drivers for the market. However, the high cost of POCT instruments may hinder the growth of the market.
Get Your Sample Today: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-molecular-point-of-care-testing-using-naat-market
North America Molecular Point Of Care Testing (using NAAT) Market Scope
North America molecular point of care testing (using NAAT) market is segmented into five notable segments which are based on product, indication, end user, mode of testing, and distribution channel.
· On the basis of indication, the North America molecular point of care testing (using NAAT) market is segmented into a sexually transmitted infection (STI) testing, respiratory infection testing, gastrointestinal tract infection testing, and others. In 2021, the respiratory segment in the molecular point of care testing (using NAAT) market is expected to dominate because of the worse condition of COVID-19 in U.S. population.
· On the basis of end user, the North America molecular point of care testing (using NAAT) market is segmented into laboratories, hospitals, clinics, ambulatory centers, home care, assisted living facilities, and others. In 2021, the laboratories segment in the molecular point of care testing (using NAAT) market is expected to dominate because of the high quality of diagnosis and research in U.S.
· On the basis of the mode of testing, the North America molecular point of care testing (using NAAT) market is segmented into prescription-based testing and OTC testing. In 2021, the prescription-based testing segment in the molecular point of care testing (using NAAT) market is expected to grow due to the fact that the use of NAAT in PCOT is new and thus requires expert advice and monitoring which increases the market for prescription-based testing.
Buy Now Access Full Report:- https://www.databridgemarketresearch.com/reports/north-america-molecular-point-of-care-testing-using-naat-market
North America Molecular Point Of Care Testing (using NAAT) Market Country Level Analysis
The U.S. is expected to dominate the North America molecular point of care testing (using NAAT) market due to the presence of excellent healthcare infrastructure, which increases the demand for molecular POCT products than other countries in North America region. The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
The countries covered in the nuts market report are
· Saudi Arabia,
· U.A.E,
· Israel,
· Egypt, and the rest of Middle East.
Major TOC of the North America Molecular Point Of Care Testing (using NAAT) Market Report
Chapter One:
CHAPTER ONE - MARKET SEGEMENTATION
CHAPTER TWO - EXECUTIVE SUMMARY
CHAPTER THREE - PREMIUM INSIGHTS
CHAPTER FOUR - MARKET OVERVIEW
Browse The Table of Contents And List of Figures https://www.databridgemarketresearch.com/toc/?dbmr=north-america-molecular-point-of-care-testing-using-naat-market
Competitive Landscape and North America Molecular Point Of Care Testing (using NAAT) Market Share Analysis
North America molecular point of care testing (using NAAT) market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to North America molecular point of care testing (using NAAT) market.
The major players covered in the Military Truck Marketreport are
· Thermo Fisher Scientific Inc.,
· Hologic, Inc.,
· BD, F. Hoffmann-La Roche Ltd,
· ABBOTT, Seegene Inc.,
· bioMérieux SA, QIAGEN,
· Bio-Rad Laboratories, Inc.,
· PerkinElmer Inc., Grifols, S.A.,
· Quidel Corporation,
· GenMark Diagnostics, Inc.,
· SD Biosensor, INC.,
· Oxford Nanopore Technologies,
· Wondfo, Randox Laboratories Ltd.,
· Meridian Bioscience, Sekisui Diagnostics,
· QuantuMDx Group Ltd., Lucira Health Inc.,
· binx health, inc., Sysmex (A Subsidiary of Sysmex Corporation), Co-Diagnostics, Inc., among others
Browse Related Reports @
North America Epoxy Curing Agents Market
Asia-Pacific Epoxy Curing Agents Market
Europe Epoxy Curing Agents Market
Europe Aesthetic services Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market
Contact:
Data Bridge Market Research
Tel: +1-888-3895-2818
